What are the steps of bronchoscopy and the different types such as endobronchial ultrasound (EBUS) and cryotherapy, and their various uses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bronchoscopy: Steps and Advanced Techniques

Bronchoscopy is performed through systematic visualization of the airways, with specialized techniques like EBUS primarily used for mediastinal/hilar lymph node sampling (requiring ≥4 needle passes for optimal yield), while cryotherapy serves dual roles in both tissue destruction for airway obstruction and high-quality tissue acquisition for diagnosis.

Standard Bronchoscopy Steps

Basic Procedure Framework

  • Airway access: Via oral or nasal route using flexible or rigid bronchoscope
  • Systematic inspection: Sequential examination of trachea, main bronchi, lobar and segmental airways
  • Targeted intervention: Based on clinical indication (diagnostic sampling, therapeutic intervention, or both)
  • Post-procedure monitoring: For complications including bleeding, pneumothorax, or respiratory compromise

EBUS (Endobronchial Ultrasound)

Primary Clinical Applications

EBUS-TBNA has become the gold standard for lung cancer diagnosis and staging of mediastinal and hilar lesions 1, 2. The technique provides real-time ultrasound guidance for needle aspiration of lymph nodes and masses adjacent to the airways.

Technical Specifications for Optimal Yield

For malignant disease 1:

  • Needle size: Use 21-gauge or 22-gauge needles (smaller preferred over 19-gauge)
  • Number of passes: Perform ≥4 needle passes (strong recommendation despite very low certainty evidence)
  • Specimen handling: Either standard alcohol-based preparations OR alternative media (formalin, RPMI, saline, PBS) are acceptable
  • ROSE (Rapid On-Site Evaluation): Suggested over usual care when available

For nonmalignant disease 1:

  • Needle size: Either 21/22-gauge OR 19-gauge acceptable (more flexibility than malignant cases)
  • Number of passes: ≥4 passes recommended
  • Collection media: Same flexibility as malignant disease
  • ROSE: Suggested when available

EBUS-Guided Cryobiopsy: Emerging Technique

EBUS-cryobiopsy provides larger, higher-quality specimens with minimal crush artifact compared to standard EBUS-TBNA 3, 4. This is particularly valuable when:

  • Diagnosing lymphoproliferative disorders requiring intact tissue architecture
  • Molecular pathology analysis needed for advanced NSCLC
  • EBUS-TBNA has diagnostic limitations (sarcoidosis, silicosis, rare metastases)

Standardized four-step approach 4:

  1. Create access pathway (via high-frequency needle knife incision or needle tract)
  2. Insert cryoprobe under ultrasound guidance
  3. Freeze-thaw cycle for tissue adherence
  4. Extract specimen with preserved architecture

For centrally located intrapulmonary lesions, EBUS-cryo through EBUS-TBNA tract achieves 95.7% diagnostic yield with 72.8% high-quality specimen retrieval rate, though moderate bleeding occurs in 5.7% of cases 5.


Cryotherapy Applications

Mechanism and Equipment

Cryotherapy uses rapid freeze-thaw cycles causing cell death, tissue necrosis, or tissue adherence 6. Delivered via:

  • Cryoprobe: Through flexible/rigid bronchoscope working channel
  • Spray cryotherapy: Direct application

Clinical Uses

1. Central Airway Obstruction (CAO) 7, 6:

  • Malignant CAO: Local cryotherapy recommended as personalized approach to reduce recurrence and prolong time to reintervention
  • Nonmalignant CAO: Part of multimodal approach including dilation, steroid injection, mitomycin C application
  • Mechanism: Tumor debulking through tissue necrosis

2. Diagnostic Cryoadhesion 6:

  • Endobronchial biopsies: Controlled data support use, though increased risk of controllable bleeding
  • Transbronchial biopsies: Active investigation area with limited controlled data
  • Advantage: Larger specimens with preserved architecture vs. forceps biopsy

3. Foreign Body Removal 6:

  • Cryoadhesion allows extraction of foreign bodies through tissue freezing and adherence

4. Low-Grade Airway Malignancy 6, 8:

  • Local treatment option for early-stage endobronchial lesions
  • May avoid or delay need for stent placement 7

Integration with Other Therapies

Cryotherapy can be combined with 7, 6:

  • Photodynamic therapy (PDT): Though PDT alone showed mean time to reintervention of 147 vs 98 days (non-significant)
  • Brachytherapy: For local disease control
  • Radiation: Promising synergy under investigation

Surveillance and Follow-up

For patients with stent placement: Routine surveillance bronchoscopy within 3 months does NOT detect complications unless patients are symptomatic 7. Therefore:

  • Symptom-driven bronchoscopy is preferred over routine surveillance
  • Use chest CT scans for stent/airway patency assessment
  • Implement mucociliary clearance interventions (hypertonic saline nebulization)

Critical Pitfalls to Avoid

  1. Inadequate EBUS sampling: Fewer than 4 needle passes significantly reduces diagnostic yield 1
  2. Wrong needle size selection: 19-gauge needles less optimal for malignant disease 1
  3. Routine surveillance bronchoscopy post-stent: Wastes resources; 84% of complications occur in symptomatic patients anyway 7
  4. Cryobiopsy bleeding: Expect moderate bleeding in ~6% of cases; ensure hemostasis capability 5
  5. Specimen handling errors: Coordinate with pathology regarding collection media based on suspected diagnosis 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.